Underwritten Offering vs. ATM. Two Very Different Ways a Biotech Raises Cash
6/02/2026
Today NRx Pharmaceuticals announced an underwritten public offering. The word
underwritten matters, because it is a very different animal from the other tool small biotechs lean on, the at-the-market program, or ATM. If you hold clinical-stage names, spotting which one you are looking at tells you a lot about what the stock is about to do.
The underwritten offering. Fast, marketed, all at once
The company hires a bank to sell a block of stock in one shot. The bank builds a book of buyers overnight, prices the shares after the close, usually at a discount to the last trade, and the new stock starts trading the next morning.
Three things to know:
It is sudden. The raise is announced, priced, and done inside a day or two. The dilution hits all at once.
It usually prices at a discount. To fill the book fast, shares go out below the market price, which is why the stock often fades the day it is announced.
The size is set. Once it prices, you know exactly how many shares were sold and at what price. Many deals also carry a greenshoe, an option for the bank to buy up to 15 percent more, which is exactly what NRx attached to this one.
The ATM. Slow, quiet, drip by drip
An at-the-market program is the opposite personality. The company files it once, then sells small amounts of stock straight into the open market over weeks or months, at whatever the going price happens to be.
Three things to know:
It is gradual. Shares trickle out a little at a time, so there is no single dilution event to trade around.
It sells at market. No fixed discount. The company sells into existing demand rather than handing buyers a markdown.
It is quiet. You often do not learn how much was sold until the next quarterly filing, so the dilution shows up after the fact.
Why the difference matters to you
An underwritten offering is a loud, one-time event. The discount and the sudden share count create a short, sharp overhang, and the stock frequently dips on the news, then settles once the deal clears and the overhang lifts. That dip is sometimes the opportunity.
An ATM is a slow leak. No dramatic gap down, but a steady headwind on the stock for as long as the program is active, because there is a quiet seller sitting on the tape every day.
Takeaway
An underwritten offering rips the band-aid off in one motion. An ATM peels it back slowly over months. Same goal, raising cash, very different effect on the chart, and very different things to watch for if you own the name.


NRXP is behaving very well post cash raise imho...
But, the markets have posted a trend reversal and only time will reveal NRXP's true value by how well the sp withstands an overall indicies wide beat down...
NRXP is my #1 gainer this year, both in Commons and Call contracts.
I think NRXP is a generational wealth builder and i have a 15% to 20% position at all times.
This cash raise was just the dip i've been waiting for in order to add a substantial lot to my Roth account as well as my Calls stack...
👍